About
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Top Deals
SOLD
Share this deal
California | Mixed-use | PPSF: $1150
01/13/2022
SOLD
Share this deal
California | Single Family Residence | PPSF: $4375000
Focus
Office
Sale
Markets
FAQs
Johnson & Johnson has financed 3 deals.
Johnson & Johnson's most recent deal was on July 02, 2025.
Johnson & Johnson's largest deals include a sale of $164,500,000.00 for 5000 Shoreline Court, South San Francisco, California 94080, United States, and a lease covering 159,959 sqft for 1600 Sierra Point Parkway.
Member since: October 2024
Deals
Transaction Type
Asset Type
State
Sort By
LEASED
Johnson & Johnson's Joaquin Duato Leases R&D Building To Nurix Therapeutics' Arthur T. Sands In Brisbane
1600 Sierra Point Parkway, Brisbane, CA
CACRE
Jul 2, 2025
SOLD
DivcoWest Acquires Mixed-Use Property In South San Francisco For $164.5M
$1,150/SF
5000 Shoreline Court, South San Francisco, California 94080, United States, South San Francisco, CA
CACRE
Jan 13, 2022
SOLD
Jaime Johnson Acquires Hollywood Hills Single Family For $17.5M With Buyer's Rep Lauren Reichenberg & Seller's Rep Timothy Di Prizito & Joyce Rey
$4,375,000/SF
Hollywood Hills, Los Angeles, California, United States, Los Angeles, CA
CACRE
May 29, 2023
SOLD
Johnson & Johnson Acquires Firefly Bio For $1 Billion To Enhance Oncology Pipeline
CRE
Jun 8, 2026